Ricerca

RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.

cerca in

Risultati 91 - 98 di 98 (tempo di esecuzione: 0.003 secondi).

esporta metadati
- RIS
- EndNote
- BibTeX
- Excel
- CSV
- RefWorks

The replication of HTLV-2 and the expression of HLA class II transcriptional activator (CIITA) are inversely correlated

2003-01-01 Casoli, C.; DE LERMA BARBARO, Andrea; Pilotti, Elisabetta; Tosi, Giovanna; Bertazzoni, U.; Accolla, Roberto

Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNF-a.

2010-01-01 E., Balza; B., Carnemolla; Mortara, Lorenzo; P., Castellani; D., Soncini; Accolla, Roberto; L., Borsi

TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA

2004-01-01 DE LERMA BARBARO, Andrea; Procopio, F. A.; Mortara, Lorenzo; Tosi, Giovanna; Accolla, Roberto

Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis

1998-01-01 DE LERMA BARBARO, Andrea; Frumento, G.; Tosi, Giovanna; Sartoris, S.; D'Agostino, A.; Soro, O.; Mingari, M. C.; Canonica, G. W.; Accolla, Roberto

Treg function as a marker to define the susceptibility to T1DM clinical onset in a healthy subject with antibodies positivity?

2012-01-01 Musolino, Gianluca; Tedeschi, A.; Salvatoni, Alessandro; Nespoli, Luigi; Accolla, Roberto

Tumor rejection and anti-tumor memory to cancer cells of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.

2009-01-01 V., Frangione; Mortara, Lorenzo; P., Castellani; DE LERMA BARBARO, Andrea; Accolla, Roberto

Tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA- autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.

2008-01-01 V., Frangione; Mortara, Lorenzo; Accolla, Roberto

Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.

2009-01-01 E., Balza; B., Carnemolla; Mortara, Lorenzo; P., Castellani; D., Soncini; Accolla, Roberto; L., Borsi

Titolo	Data di pubblicazione	Autore(i)
The replication of HTLV-2 and the expression of HLA class II transcriptional activator (CIITA) are inversely correlated	1-gen-2003	Casoli, C.; DE LERMA BARBARO, Andrea; Pilotti, Elisabetta; Tosi, Giovanna; Bertazzoni, U.; Accolla, Roberto
Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNF-a.	1-gen-2010	E., Balza; B., Carnemolla; Mortara, Lorenzo; P., Castellani; D., Soncini; Accolla, Roberto; L., Borsi
TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA	1-gen-2004	DE LERMA BARBARO, Andrea; Procopio, F. A.; Mortara, Lorenzo; Tosi, Giovanna; Accolla, Roberto
Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis	1-gen-1998	DE LERMA BARBARO, Andrea; Frumento, G.; Tosi, Giovanna; Sartoris, S.; D'Agostino, A.; Soro, O.; Mingari, M. C.; Canonica, G. W.; Accolla, Roberto
Treg function as a marker to define the susceptibility to T1DM clinical onset in a healthy subject with antibodies positivity?	1-gen-2012	Musolino, Gianluca; Tedeschi, A.; Salvatoni, Alessandro; Nespoli, Luigi; Accolla, Roberto
Tumor rejection and anti-tumor memory to cancer cells of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	1-gen-2009	V., Frangione; Mortara, Lorenzo; P., Castellani; DE LERMA BARBARO, Andrea; Accolla, Roberto
Tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA- autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.	1-gen-2008	V., Frangione; Mortara, Lorenzo; Accolla, Roberto
Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.	1-gen-2009	E., Balza; B., Carnemolla; Mortara, Lorenzo; P., Castellani; D., Soncini; Accolla, Roberto; L., Borsi

Risultati 91 - 98 di 98 (tempo di esecuzione: 0.003 secondi).

↑ Back to top

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Aggiungere filtri:

Aggiungi

Opzioni

Risultati/pagina

Ordina per

In ordine

Scopri

Accesso al fulltext

no fulltext 69
reserved 22
open 7

The replication of HTLV-2 and the expression of HLA class II transcriptional activator (CIITA) are inversely correlated

Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNF-a.

TPA-mediated down-regulation of MHC class II gene expression in human macrophage precursors by destabilization of the MHC-II transactivator (CIITA) mRNA

Transient internalization and/or block of export to the cell surface of HLA Class II and CD1b molecules after bacterial phagocytosis

Treg function as a marker to define the susceptibility to T1DM clinical onset in a healthy subject with antibodies positivity?

Tumor rejection and anti-tumor memory to cancer cells of different histotype genetically modified to express CIITA-driven autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.

Tumor rejection and anti-tumor memory to neoplasias of different histotype genetically modified to express CIITA- autologous MHC class II genes. A new strategy of anti-tumor vaccination and tumor immunotherapy.

Tumor targeted IL-2 and TNF alpha trigger a synergistic T cell-mediated therapeutic effect against mouse neuroblastoma.

Legenda icone

Aggiungere filtri:

Opzioni

Scopri

Tipologia

Autore

Data di pubblicazione

Rivista

Keyword

Lingua

Accesso al fulltext